To establish whether the expression levels of DLEU1, DYNLL1, and BCL2 are clinically associated, we evaluated DLEU1 RNA expression by RNAscope and evaluated the protein levels of DYNLL1 and BCL2 by immunohistochemistry staining in ESCC tissues. This evidence concerns the gene BCL2 and esophageal squamous cell carcinoma.